Document is current

Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin’s lymphoma

Crossref DOI link: https://doi.org/10.1007/s11523-015-0359-8

Published Online: 2015-02-01

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy